跳至主要内容
临床试验/ITMCTR2200006471
ITMCTR2200006471尚未招募4 期

Clinical study of Wuling capsule combined with nucleoside analogues in the treatment of chronic hepatitis B hypoviremia

The Third Hospital of Hebei Medical University0 个研究点开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • (1) Age 18~65
  • (2) Patients with chronic hepatitis B hypoviremia (HBV DNA 20~2000 iu/ml) can be diagnosed in combination with previous medical history
  • (3) TCM syndrome differentiation is liver depression and spleen deficiency with blood stasis;
  • (4) Patients who voluntarily sign informed consent

排除标准

  • (1) Patients with other virus infections (HAV, HCV, HDV, HEV, CMV, EBV, HIV);
  • (2) Patients with severe hepatitis and liver cancer such as drug liver, alcoholic liver disease or nonalcoholic fatty liver;
  • (3) Pregnant or lactating patients;
  • (4) Patients who have participated in other clinical trials or participated in other drug clinical trials for less than 1 month

研究者

相似试验

Clinical study of Wuling capsule combined with... | 临床试验